LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_004329.3:c.1420G>C
BMPR1A
· NP_004320.2:p.(Val474Leu)
· NM_004329.3
GRCh37: chr10:88683210 G>C
·
GRCh38: chr10:86923453 G>C
Gene:
BMPR1A
Transcript:
NM_004329.3
Final call
VUS
PM2 supporting
Variant details
Gene
BMPR1A
Transcript
NM_004329.3
Protein
NP_004320.2:p.(Val474Leu)
gnomAD AF
7.68163346218654e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: gnomAD v4.1 grpmax FAF is 0.00008424, below the generic supporting threshold of 0.0001.
Final determination:
Under generic ACMG/AMP 2015 rules, one supporting criterion alone satisfies none of the pathogenic, likely pathogenic, benign, or likely benign combinations, so the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not met | Not met: no established pathogenic BMPR1A variant causing p.Val474Leu was identified, while the exact variant has conflicting ClinVar submissions. |
clinvar
PMID:25980754
|
| PS2 | Not assessed | Not assessed: no documented proband phenotype, family history, or confirmed maternity and paternity testing establishes a de novo occurrence. |
|
| PS3 | Not assessed | Not assessed: no variant-specific validated functional assay or reviewed functional evidence was identified for BMPR1A c.1420G>C (p.Val474Leu). |
oncokb
PMID:25980754
PMID:25741868
|
| PS4 | Not met | Not met: no exact-variant affected-versus-control counts, odds ratio, or 95% confidence interval were reported to satisfy OR >5.0 with CI excluding 1.0. |
PMID:25980754
PMID:15604628
|
| PM1 | Not assessed | Not assessed: p.Val474Leu may lie in an annotated kinase domain, but a well-established critical domain without benign variation is not documented. |
clinvar
|
| PM2 | Met | Met at supporting strength: gnomAD v4.1 grpmax FAF is 0.00008424, below the <=0.0001 PM2 threshold. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| PM3 | Not assessed | Not assessed: inheritance mode, a pathogenic second allele, affected-proband data, and parent or offspring phase testing are not documented. |
PMID:15604628
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not met | Not met: no different pathogenic missense change at BMPR1A residue Val474 is documented in the available evidence. |
clinvar
PMID:25980754
|
| PM6 | Not assessed | Not assessed: no documented assumed de novo occurrence or parental testing is available for this variant. |
|
| PP1 | Not assessed | Not assessed: no affected relatives, matching phenotypes, variant genotypes, or informative meioses are documented. |
|
| PP2 | Not assessed | Not assessed: BMPR1A loss-of-function disease evidence is available, but no benign-missense rate and common-missense-mechanism evidence are documented. |
pvs1_gene_context
|
| PP3 | Not met | Not met: missense REVEL score 0.454 is below the generic PP3 supporting threshold of >=0.644. |
revel
|
| PP4 | Not assessed | Not assessed: the patient's phenotype and family history are not provided, so specificity for a single BMPR1A-related disease etiology cannot be judged. |
|
| PP5 | Not met | Not met: ClinVar has zero expert-panel submissions and no exact-variant Pathogenic or Likely pathogenic expert-panel classification. |
clinvar
PMID:25980754
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00008424, far below the 0.05 BA1 threshold. |
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00008424, below the generic 0.01 BS1 threshold. |
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports 0 homozygotes but no documented healthy adult carrier with age and phenotype information. |
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific validated assay showing preserved BMPR1A protein function or splicing was identified for c.1420G>C (p.Val474Leu). |
oncokb
PMID:25980754
PMID:25741868
|
| BS4 | Not assessed | Not assessed: no tested affected relatives lacking the variant are documented, and phenocopy or multiple-variant explanations cannot be evaluated. |
|
| BP1 | Not assessed | Not assessed: BMPR1A loss-of-function evidence exists, but the evidence does not show that disease is caused primarily by truncating variants. |
pvs1_gene_context
|
| BP2 | Not assessed | Not assessed: no individual-level co-occurrence with a pathogenic variant or phase result establishes cis or trans for this variant. |
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: missense REVEL score 0.454 exceeds the generic BP4 supporting threshold of <=0.29. |
revel
|
| BP5 | Not assessed | Not assessed: no case-level alternate molecular diagnosis or second causal variant is documented for this patient. |
|
| BP6 | Not met | Not met: the benign and likely benign ClinVar assertions are single-laboratory submissions, with zero exact-variant expert-panel submissions. |
clinvar
PMID:25980754
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.